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How fatal is breast cancer? A prospective study of breast carcinoma
deaths in Tayside
D.M. Parham, A.J. Robertson, W. Guthrie & J. Swanson Beck
Department ofPathology, Ninewells Hospital and Medical School, Dundee, DDI 9SY, Scotland, UK.
Summary A prospective autopsy study of deaths of women who had been diagnosed previously as having
cancer of the breast was performed between October 1986 and December 1990. During the study period 28
deaths occurred and nine of these (32%) were attributable directly to breast cancer; a figure similar to that
found in our earlier retrospective study. In this study the autopsy findings in both the breast cancer and
non-breast cancer deaths were recorded and five cases underwent post-mortem radiological skeletal survey to
detect metastases. The findings confirm the role of the post mortem in modern medicine as a method of
auditing clinical practice. Of particular importance, is the finding that the clinical presumption ofdisseminated
breast cancer as a cause of 'terminal' illness in some patients may be misleading and dangerous, possibly
denying some patients treatment of potentially remedial conditions by the institution of inappropriate terminal
care.
Carcinoma of the breast occurs in one in 12 women in the
United Kingdom. Our understanding of the natural history
of breast carcinoma is limited and despite considerable effort
treatment does not seem to have altered significantly the
overall long term survival for these patients. Statistics show
that the proportion of patients treated for breast cancer
between 1936 and 1949 and surviving 5 years (55%; Bloom et
al., 1962), is similar to the 5 year crude survival rate for
Scotland in 1981-85 (53%; SHHD, 1989). In the former
study it should be noted that survival was calculated from
the onset of symptoms. It is possible that any apparent
improvement in survival now reported may be due to better
selection of treatment groups or the earlier detection of the
tumour.
In a previous study (Parham & Robertson, 1989) we found
that only 29% of autopsied patients with a history of breast
cancer died as a direct consequence of breast carcinoma. This
was considerably lower than the results of two previous
studies published by Hagemeister et al. (1980) and Cho &
Choi (1980) of 92% and 84% respectively. We therefore
decided to conduct a prospective study to verify our original
findings.
Materials and methods
Prospective study
All autopsy requests and accompanying case notes between
October 1986 and December 1990 were reviewed prior to
port mortem examination for women with a history of breast
carcinoma. As in the previous study (Parham & Robertson,
1989), no Coroner/Procurator Fiscal autopsies are included.
Cases first diagnosed on their last admission to hospital and
who had not received treatment were excluded. A total of 28
cases were found with previous breast carcinoma. Infor-
mation regarding non-surgical treatment modalities and men-
strual status was generally not available.
In parallel with this study we decided also to autopsy
women dying in Tayside who were part of the UK Early
Detection of Breast Cancer Trial. This was a large multi-
centre population based 7 year trial of regular breast screen-
ing. It involved about 240,000 women between the ages of
45-65 in eight districts. Two districts offered mammography
and clinical examination, two education in breast self exam-
ination and four acted as reference centres. Dundee was one
of the latter. There were 203 women diagnosed with breast
cancer during the trial period of 1980-1984. These women
were followed and during the period of our autopsy project
(between October 1986 and December 1990) 36 of these 203
patients died. Serious attempts were made to obtain post-
mortems on all these 36 patients, but unfortunately permis-
sion for necropsy examination was granted for only five
patients. These are included in the data on all 28 cases during
our study period. In two of these five cases autopsy had been
requested to establish the cause of death and in the other
three to confirm the clinical diagnosis of a breast cancer
death.
Cause ofdeath
Clinical cause of death The autopsy request form has sec-
tions to be completed by the requesting clinician. These
include details about the course and management of the
current illness, presumptive diagnosis at death, outstanding
problems, previous operations and histopathology reports.
The autopsy request was usually completed by the junior
doctor in the team responsible for the patient at the time of
death. The presumptive diagnosis from the autopsy request
form, confirmed by review of the case notes was used to
ascertain the clinical cause of death.
Autopsy} cause of death Information from the autopsy re-
quest form, clinical summaries and autopsy findings were
considered together to determine the cause of death. Death
was considered to have resulted from breast carcinoma if (A)
extensive secondaries involved major organs, (B) the car-
cinoma had given rise to major infection (e.g. bronchopneu-
monia) or sepsis, (C) the tumour was a source of significant
haemorrhage, (D) when metastatic disease had given rise to
immobility and deep venous thrombosis leading to a pul-
monary embolus. Death was attributed to unrelated disease,
(e.g. myocardial infarction) when this occurred in the absence
of significant metastatic carcinoma. The presence of the
occasional small microscopic focus of metastatic carcinoma
in, for example a lymph node or kidney (when these organs
were not considered to be involved in the cause of death)
would be considered insignificant, if in agreement with the
clinical findings.
All necropsies were performed at Ninewells Hospital and
Medical School. In all cases, all the major organs and any
gross or radiological abnormality noted were examined in
detail and sampled for subsequent histology. As part of the
study the five patients, who were part of the UK Early
Detection of Breast Cancer Study, underwent a post mortem
radiological skeletal survey to detect bony secondaries.
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Results
A summary of the patient data is shown in Table I. The
results from the five breast screening trial cases are similar to
the 23 other cases and do not distort the overall findings of
the study. All 28 cases had a history of invasive mammary
carcinoma of no special histological type. The seven cases
receiving non-surgical treatment were diagnosed by fine
needle aspiration cytology (five cases), trucut biopsy (one
case) or clinically (one case confirmed at autopsy).
Review of the necrospsy findings showed that nine of the
28 cases (32%) died as a direct consequence of breast car-
cinoma. The survival time of these nine cases was not
significantly shorter than the 19 non-breast carcinoma deaths
(median survival of 60 months as opposed to 92 months,
Mann Whitney U Test P = 0.25). In the nine breast cancer
deaths the terminal events were; bronchopneumonia four
cases, carcinomatosis four cases, pulmonary embolus one
case.
Clinical judgement confidently thought that breast cancer
was the direct cause of death in nine cases. This clinical
opinion was confirmed by necropsy in seven cases (78%)
with the other two patients dying of bronchopneumonia and
ischaemic heart disease. In six further cases breast carcinoma
was raised as a possible cause of death by the clinicians
managing these patients but autopsy confirmed this in only
two cases (33%). A summary of these results together with
the findings from our previous study are shown in Table II.
From the table (using all the data) the sensitivity and
specificity of the clinical opinion as to the cause of death can
be determined. Using definite breast cancer as the cut-off
point, clinical judgement as to the cause ofdeath has an 82%
sensitivity and 89% specificity. If possible breast cancer is the
cut-off point clinical judgement has a sensitivity of 91% and
specificity of 71%.
The causes of death in the six patients who were thought
clinically to have definitely or possibly died of breast cancer
but died of other causes are shown in Table III. No case
where breast carcinoma was established at necropsy as the
cause of death was missed clinically. The major pathologies
causing death in the patients not succumbing to breast car-
cinoma are listed in Table IV.
The incidence and distribution of metastases is shown in
Table V. Of the 19 patients who died of other disease, six
had residual breast carcinoma at the following sites: local
disease (five cases), regional lymph nodes (three cases), bone
(one case). These figures include the cases treated by non
surgical modalities.
A radiological skeletal survey was performed in five cases.
In one case X-ray detected bony metastases and this was
confirmed at autopsy. In one case radiology was suspicious
of metastases and this was not confirmed. In three cases
X-ray did not reveal any lesion but subsequent autopsy
revealed microscopic bony deposits in one case.
Discussion
The population characteristics of the cases in this study differ
little from those in the previous study (Parham & Robertson,
1989). The results are very similar, although in this study the
survival times for those that died as a direct result of breast
cancer are not significantly different (in statistical terms)
from the non-breast cancer deaths, probably due to the small
numbers involved. All cases were invasive mammary car-
cinomas of no special histological type. It is of interest that a
Table I A summary of patients autopsied between October 1986 to December
1990
UK early detection
of breast cancer Non trial
patients patients All cases
Number of
Autopsies 5 23 28
Average age 59 years 59 years 59 years
Median survival 54 months 87 months 85 months
(range 3-489,
61% 5yr survival)
Tumour site
Left 1 14 15
Right 3 9 12
Bilateral 1 0 1
Treatment
Mastectomy 5 13 18
Lumpectomy 0 4 4
Non-surgical 0 7 7
Treatment
Outcome
Breast cancer deaths 3 6 9
(Median survival
60 months)
Non-breast cancer deaths 2 17 19
(Median survival
92 months)
Table II A comparison of the clinical opinion as to the cause of death and autopsy
findings. Data in brackets refer to larger retrospective study
Autops,y
Clinical opinion Breast cancer Other cause Total
(a) Definitely breast cancer 7 (21) 2 (6) 9 (27)
(b) Possibly breast cancer 2 (1) 4 (10) 6 (11)
(c) Definite/possible other cause 0 (2) 13 (40) 13 (42)
(d) Cause uncertain 0 (1) 0 (1) 0 (2)
Total 9 (25) 19 (57) 28 (82)
aExcludes three cases from the original study (one in each clinical category a,b,c,)
where the autopsy findings were equivocal as to the contribution that breast cancer
made to death.1088 D.M. PARHAM et al.
Table III Causes of death in patients thought clinically to have
definitely or possibly have died of breast cancer but died of other
causes
Ischaemic heart disease 2 cases
Pyelonephritis 1 case
Septaecaemia 1 case
Aspergillous bronchopneumonia 1 case
Ovarian carcinoma 1 case
Table IV Major pathology in all non-breast carcinoma deaths
Cardiovascular system
Ischaemic heart disease 4 cases
Ruptured aortic aneurysm 1 case
Respiratory system
Chronic obstructive airways disease 2 cases
Bronchopneumonia 1 case
Pulmonary embolus 2 cases
Aspergillous bronchopneumonia I case
Bronchial carcinoma 1 case
Gastrointestinal tract
Complications of peptic ulceration 2 cases
Diverticulitis 1 case
Genital urinary system
Ovarian carcinoma 1 case
Pyelonephritis 1 case
Haematological
Polycythemia rubra vera 1 case
Soft tissue
Myxoid liposarcoma 1 case
Table V Distribution of metastases in all 28 patients with breast
carcinoma (figures in brackets is the number of microscopic
metastases)
Percentage Previous study*
Number (%) (%)
Heart 0 0 4
Pericardium 2 (1) 7 8
Heart+pericardium 2 (1) 7 10
Lungs 4 (1) 14 21
Lungs + pleura 6 (3) 21 27
Gastrointestinal tract 0 0 4
Liver 6 21 22
Peritoneum 3 11 5
Pancreas 1 4 1
Kidneys 1 4 2
Adrenals 3 11 5
Spleen 1 4 1
Ovaries 1 4 1
Regional LN 8 (1) 28 13
General LN 5 18 12
Bone 7 (1) 25 20
Muscle (not local) 1 4 1
Brain 1 4 5
Meninges 1 4 2
Brain +meninges 2 7 6
*Parham & Robertson, 1989.
greater proportion of patients were treated conservatively in
this study compared to that previously reported. This may
reflect changes in the management of breast cancer in recent
years but the numbers involved (seven cases) are small and
the figures may be misleading. The results from the radiology
skeletal surveys although small in number suggest radiology
is relatively accurate and sensitive at detecting bone metas-
tases compared with clinical examination.
This project and our previous study (Parham & Robertson,
1989) have shown that approximately 30% of autopsied
breast cancer patients die as a direct consequence of the
disease. This figure is substantially less than the results
reported by other groups (84%-92%; Hagemeister et al.,
1980; Cho & Choi, 1980). The patients in the study by Cho
& Choi (1980) had only a 24% 5 year survival. Comparable
figures are not available for the study by Hagemeister et al.
(1980) although the disease free interval was only 17 months.
This would imply either a difference in the type of disease
with a more aggressive disease in the USA, or a difference in
response to treatment. A more likely explanation is that there
is a degree of autopsy selection suggesting that either their
cases, or ours are not necessarily representative of a typical
population of breast cancer patients. The 61% survival at 5
years observed in this study suggests that, as in our previous
study (Parham & Robertson, 1989), our population is not
unduly biased.
The accuracy of death certification has been questioned by
others (Nemetz et al., 1987): major discrepancies between
antemortem and postmortem diagnoses have been docu-
mented in 7-39% of autopsies. Our study has found similar
results. Where death was attributable clinically to breast
cancer this was confirmed at autopsy in only 78% of cases
and this figure is similar to that found in our previous study
(Parham & Robertson, 1989). The results also continue to
indicate that there is a strong clinical tendency to over-
diagnose cancer as the cause of death when breast cancer has
been diagnosed in earlier life. Over-reliance on a presumptive
diagnosis of disseminated breast cancer based on clinical
grounds alone without pathological confirmation is poten-
tially very dangerous. While we did not observe any definite
case of inappropriate terminal care being given in this or our
previous study (Parham & Robertson, 1989), potentially
treatable conditions were not diagnosed and remained un-
treated. Clearly this is important as it raises the possibility
that in a wider context some patients may be receiving
inappropriate terminal care when they have potentially
treatable (and even curable) disease. Our findings are derived
solely from autopsies requested by hospital practitioners. The
diagnostic accuracy of general practitioners is unlikely to be
better and indeed may be poorer due to the lack of facilities
for the investigation of patients outside hospital. This is of
concern as there is a greater tendency for patients to receive
terminal care at home, where elimination of treatable ter-
minal illness is not possible and inappropriate terminal care
may be given.
The inaccuracy of information regarding breast cancer
mortality is disturbing, particularly with regard to determin-
ing the efficacy of breast cancer screening. Indeed in the
Malmo breast screening trial (Andersson et al., 1988), where
approximately 76% of patients deaths underwent autopsy it
was not rare to find an alternative cause of death in patients
who were clinically thought to have died of breast cancer. If
the true mortality of non-screened breast cancer remains
unclear then the results from any study of screen detected
tumours are bound to be questionable, although, if the
tendency is to over-attribute breast cancer as a cause of
death, this would tend to mask any real reduction in mor-
tality attributable to screening.
It is disappointing that there was a slight decrease in the
proportion of breast cancer autopsies between our study
published previously and this one (4.5%, 85 autopsies out of
1987 registered breast cancers deaths over a 163 month
period, compared with 3.7%, 28 autopsies out of 754 reg-
istered breast cancer over a period of 51 months). Indeed if
the five autopsies from the breast cancer screening trial are
excluded the drop in the proportion of cases would have
been greater (3.2%). It is discouraging that only five of the
36 deaths, in patients diagnosed with breast cancer as part of
the UK Early Detection of Breast Cancer Screening Trial,
came to autopsy despite considerable efforts having been
made to persuade general practitioners and clinicians as to
the value of the study. At the start all General Practitioners
and Hospital Consultants in the Dundee area were contacted
regarding the importance of obtaining an autopsy specifically
on these patients. They all received written details of the
study and many were contacted informally. The poor autop-
sy rate may in part be due to a reluctance on behalf of
doctors to further distress relatives at the time of the bereave-
ment and possibly the perceived financial and administrative
costs incurred by a General Practitioner in arranging an
autopsy in spite of all transport costs being borne by the
hospital service. This contrasts the high autopsy rate for HIVBREAST CANCER DEATHS 1089
deaths in our area where there is a high level of clinical
concern by the clinicians.
The decline in autopsy rates in general is of concern and
the reasons for this have been discussed in detail elsewhere
(Nemetz et al., 1987). Nevertheless the autopsy plays a
critical role in modern medicine being a definitive method of
quality control and audit. The results provide accurate mor-
tality data for clinical research, treatment, public health plan-
ning. It is worrying that the introduction of resource man-
agement and clinical budgeting may further reduce the
number of autopsies, where there is clear evidence to suggest
that structured collection of autopsy data is necessary for
medical research.
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